Abstract
Molecular disease mechanisms typically constitute abnormalities in the regulation of genes producing many kinds of alterations in the expression levels. To identify disease-altered genes better, we have developed an approach that searches for the genes which present a significant rank alteration in the rank of their expression profiles, by comparing an altered rank with another gene. The approach provides groups of genes and assigns a statistical measure of significance to each pair of genes selected. The method is evaluated using two experimental sets of microarrays. We investigated the possibility of inferring the rank reverse pairs and its possibility in diagnostic application when there is no prior knowledge of the genes belonging to disease, nor about the structure of gene regulatory network. We also show that rank reverse is a very powerful technique to diagnostic disease in the practical application and could be used prior to traditional biomarker discovery.
Keywords: Rank reverse, gene expression, diagnostic approach, chip, disease-altered gene
Current Bioinformatics
Title: Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression
Volume: 4 Issue: 3
Author(s): Wenguang Zhang, Jinquan Li, Rui Su and Wu Jianghong
Affiliation:
Keywords: Rank reverse, gene expression, diagnostic approach, chip, disease-altered gene
Abstract: Molecular disease mechanisms typically constitute abnormalities in the regulation of genes producing many kinds of alterations in the expression levels. To identify disease-altered genes better, we have developed an approach that searches for the genes which present a significant rank alteration in the rank of their expression profiles, by comparing an altered rank with another gene. The approach provides groups of genes and assigns a statistical measure of significance to each pair of genes selected. The method is evaluated using two experimental sets of microarrays. We investigated the possibility of inferring the rank reverse pairs and its possibility in diagnostic application when there is no prior knowledge of the genes belonging to disease, nor about the structure of gene regulatory network. We also show that rank reverse is a very powerful technique to diagnostic disease in the practical application and could be used prior to traditional biomarker discovery.
Export Options
About this article
Cite this article as:
Zhang Wenguang, Li Jinquan, Su Rui and Jianghong Wu, Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression, Current Bioinformatics 2009; 4 (3) . https://dx.doi.org/10.2174/157489309789071039
DOI https://dx.doi.org/10.2174/157489309789071039 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Treatment of Different Breast Cancers
Anti-Cancer Agents in Medicinal Chemistry Clinical Impact of Gene Expression Profiling on Oncology Diagnosis, Prognosis, and Treatment
Combinatorial Chemistry & High Throughput Screening Intracellular Calcium, Endothelial Cells and Angiogenesis
Recent Patents on Anti-Cancer Drug Discovery Signaling Processes in Tumoral Neuroendocrine Pituitary Cells as Potential Targets for Therapeutic Drugs
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Endothelin Axis as Therapeutic Target in Human Malignancies: Present and Future
Current Pharmaceutical Design Role of microRNA Deregulation in Breast Cancer Cell Chemoresistance and Stemness
Current Medicinal Chemistry Application of Pharmacogenomics to Dietary Cancer Chemoprevention
Current Pharmacogenomics A Mechanistic Overview on Male Infertility and Germ Cell Cancers
Current Pharmaceutical Design Kinase Phosphorylation-based Mechanisms of PARP Inhibitor Resistance During Synthetic Lethal Oncotherapy
Current Signal Transduction Therapy Novel Insight into the Inflammatory and Cellular Responses Following Experimental Glaucoma Surgery: A Roadmap for Inhibiting Fibrosis
Current Molecular Medicine Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores
Current Organic Chemistry Commentary on “Non-Steroidal Anti-inflammatory Drugs Loaded Liposomes for Topical Treatment of Inflammatory and Degenerative Conditions” by Carla Matos, FP-ENAS-UFP Energy, Environment and Health Research Unit/CEBIMED-Centro de Estudos em Biomedicina, Fernando Pessoa University, Porto, Portugal Challenges and Prospects of Topical Treatment of Inflammatory and Degenerative Conditions: A Vesicular Approach
Current Medicinal Chemistry Molecular Targets of Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Fluorine-18 Labeled Amino Acids for Oncologic Imaging with Positron Emission Tomography
Current Topics in Medicinal Chemistry Nutriproteomics – Linking Proteomics Variation with Personalized Nutrition
Current Pharmacogenomics and Personalized Medicine Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations
Current Drug Targets Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications
Current Enzyme Inhibition Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Current Cancer Drug Targets TNF-α Induction by Nickel Compounds is Specific Through ERKs/AP-1- Dependent Pathway in Human Bronchial Epithelial Cells
Current Cancer Drug Targets Turning REST/NRSF Dysfunction in Huntingtons Disease into a Pharmaceutical Target
Current Pharmaceutical Design